Nurix Therapeutics, Inc. NRIX Deferred Tax Liabilities Operating Lease Right Of Use Assets
Deferred Tax Liabilities Operating Lease Right Of Use Assets at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept nrix:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets.
The official record: Nurix Therapeutics, Inc.’s 10-K, filed January 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s deferred tax liabilities operating lease right of use assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s deferred tax liabilities operating lease right of use assets?
- Nurix Therapeutics, Inc. (NRIX) reported deferred tax liabilities operating lease right of use assets of $14.43M in Q3 2025.
- What does deferred tax liabilities operating lease right of use assets mean?
- Represents the deferred tax liability arising from the temporary difference between the book value and tax basis of operating lease right-of-use assets. It highlights the tax implications of accounting for lease assets under current financial reporting standards.